Paglinawan, Silvestra D.

HRN: 22-86-73  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/14/2023
CEFUROXIME 750MG (VIAL)
04/14/2023
04/21/2023
IV
750 Mg
Q8hrs
UTI
10/16/2023
CEFTRIAXONE 1G (VIAL)
10/16/2023
10/23/2023
IVT
2g
OD
PTB
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: